UCB - Assets

Stock Price
250.40
Daily Change
0.80 0.32%
Monthly
-11.68%
Yearly
35.39%
Q1 Forecast
243.41

UCB reported EUR17.35B in Assets for its fiscal semester ending in December of 2024.





Assets Change Date
Alcon AG USD 31.56B 31M Dec/2025
Almirall EUR 2.34B 29.21M Dec/2025
Amarin USD 659.81M 10.31M Sep/2025
argenx SE USD 7.18B 973.07M Jun/2025
AstraZeneca USD 114.07B 382M Dec/2025
Bayer EUR 104.54B 331M Dec/2025
Galapagos EUR 3.41B 105.39M Dec/2025
Genmab DKK 6.46B 122M Jun/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
GRIFOLS EUR 19.71B 141.77M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 19.73B 1.85B Dec/2024
Merck EUR 51.53B 600M Dec/2025
Novartis USD 107.29B 2.89B Sep/2025
Orion EUR 2.01B 262M Dec/2025
Recordati EUR 5.3B 122.58M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
UCB EUR 17.35B 1.72B Dec/2024
Unibail Rodamco EUR 53.55B 298.5M Dec/2024